A library of twelve N(4 )-substituted di-tert-butyl (2S,4E)-4-arylaminomethylidene-5-oxopyrrolidine-1,2-dicarboxylates 6/6 a -l were prepared in 47 -90 % yield by parallel acid-catalysed treatment of di-tert-butyl (2S,4E)-4-[(dimethylamino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (4) with anilines 5a -j, ethyl glycinate (5k), and ethyl β -alaninate (3l). Acidolytic deprotection of compounds 6a -c, e -j afforded the corresponding (2S,4E)-4-arylaminomethylidene-5-oxopyrrolidine-2-carboxylic acids 7a -c, e -j in 39 -99 % yield. The configuration around the C=C double bond in the enaminones 6 and 7 was determined by NMR spectroscopy.
Introduction
(S)-Pyroglutamic acid (1) is a naturally occurring heterocyclic α-amino acid which is abundant in peptides and proteins, and its structure can also be found in a variety of other biologically important compounds. On the other hand, 1 is also a useful chiral building block, which is frequently used as a commercially available starting material in chiral-pool syntheses of peptidomimetics, natural products, and their analogues. Therefore it is not surprising, that several reviews on the chemistry of (S)-pyroglutamic acid (1) have recently been published [1] .
2-Substituted alkyl 3-(dimethylamino)prop-2-enoates and related enaminones are a group of enaminomasked alkyl α-formylacetates, which are easily available and versatile reagents in heterocyclic synthesis [2] . In addition to their extensive use in the synthesis of various heterocyclic systems, recent applications of enaminones have mostly focused on the synthesis of functionalised heterocyclic compounds including natural product analogues [2 -4] , and on combinatorial syntheses of functionalised heterocycles [5] . Within this context, various functionalised enaminones have been prepared and used as key intermediates in the synthesis of 3-heteroarylalanine derivatives [6] , histamine analogues [5b, 7] , and het-0932-0776 / 10 / 0700-0811 $ 06.00 c 2010 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com erocyclic analogues of dipeptides containing the (S)-pyroglutamic acid structural motif [5c, 8] . Previously, we reported the synthesis of a series of N(4 )-substituted methyl (2S,4E)-1-acyl-4-(aminomethylidene)-5-oxopyrrolidine-2-carboxylates as stable intermediates in the 'ring switching' synthesis of 3-heteroarylalanines [9] . Recently, this type of compounds attracted our attention again, since such α-enamino pyroglutamic acids are conformationally constrained heterocyclic dipeptides comprising α,β -dehydro-β -alanine (∆-β -Ala) and (S)-alanine (L-Ala) structural units (Fig. 1) .
Therefore, we were intrigued to study the synthesis of γ-enamino pyroglutamic acids 7, which might be interesting and useful building blocks for further derivatisation. Herein, we report the result of this study -a simple parallel solution-phase pyroglutamic acid (1) following the literature procedures [5c, 10, 11] . Thus, acid-catalysed esterification of (S)-pyroglutamic acid (1) with tert-butyl acetate gave tert-butyl pyroglutamate (2) [10] , which was N-acylated with Boc 2 O in acetonitrile in the presence of catalytic amounts of 4-dimethylaminopyridine (DMAP) to afford di-tert-butyl (2S)-5-oxopyrrolidine-1,2-dicarboxylate (3) [11] . Finally, heating of 3 with one equivalent of tert-butoxy-bis(dimethylamino)methane (Bredereck s reagent, TBDMAM) furnished di-tert-butyl (2S,4E)-4-[(dimethylamino)-methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (4) in 70 % yield over three steps [5c] (Scheme 1).
Further parallel treatment of the enamino lactam 4 with 1.2 equivalents of amine hydrochlorides 5a -l in 50 % aqueous ethanol at r. t. resulted in the formation of the dimethylamine substitution products, N(4 )-substituted di-tert-butyl (2S,4EZ)-4-aminomethylidene-5-oxopyrrolidine-1,2-dicarboxylates 6/6 a -l, which precipitated from the reaction mixtures and were isolated by filtration. Upon washing with water and thorough drying in vacuo over P 4 O 10 , a library of twelve analytically pure esters 6/6 a -l was obtained in 47 -90 % yield. In the final step, parallel acidolytic deprotection of compounds 6/6 a -l was carried out. Stirring of esters 6/6 with 2 M HCl/EtOAc at r. t. for 12 h resulted in the initial formation of clear colourless or yellow solutions followed by formation of precipitates, which were then collected by filtration, washed with EtOAc, and dried in vacuo over P 4 O 10 . In this manner, analytically pure carboxylic acids 7a -c, e -j were prepared in 37 -99 % yield. Acidolysis of compounds 6d, k, l did not produce precipitates. Attempts to isolate the final products 7d, k, l by evaporation of the reaction mixtures followed by crystallisation and/or chromatographic workup failed. Since we were particularly interested in a simple and practical procedure using just a filtration work-up, no further attempts to isolate compounds 7d, k, l were made (Scheme 1, Table 1 ).
The structures of the novel compounds 6/6 a -l and 7a -c, e -j were determined by spectroscopic (NMR, IR, MS) methods and by elemental analyses. The configuration around the exocyclic C=C bond in compounds 6a, 6 a, and 7i was determined by HMBC NMR spectroscopy on the basis of the long-range coupling constant ( 3 J C−H ) between the methylidene proton (H-C (4 )) and the carbonyl carbon atom (O=C(5)), measured from the antiphase splitting of cross peaks. Generally, the magnitude of this coupling constant, 3 J C−H , for nuclei with cis-configuration around the C=C double bond is smaller (2 -6 Hz) than that for trans-oriented nuclei (8 -12 Hz) [2, 12] . In compounds 6a and 7i, the magnitude of the coupling constants, 3 J C(1)−H(4 ) = 4 Hz (cis) and 5 Hz (cis), respectively, confirmed the (E)-configuration around the exocyclic C=C double bond. In the minor isomer 6 a, on the other hand, a large coupling constant, 3 J C(1)−H(4 ) = 10 Hz (trans), confirmed the (Z)-configuration around the C=C double bond (Fig. 2) . Additionally, the configuration around the exocyclic C=C double bond in compounds 6a, 6 a, and 7h -j was confirmed by NOESY spectroscopy. A NOE between the NH and the CH 2 group in compounds 6a and 7h -j was in agreement with the (E)-configuration around the exocyclic C=C double bond, whilst a NOE between the 4 -H and the CH 2 group in the minor isomer 6 a supported the (Z)-configuration (Fig. 2) .
Finally, the configurations around the C=C double bond in compounds 6 and 7 were confirmed by correlation of chemical shifts for 4 -H and NH and vicinal coupling constants, 3 J H−H . The major and most characteristic difference was observed in chemical shifts δ for the aminomethylidene -NH-CH= protons. In the 1 H-NMR spectra of the E/Z-mixtures 6/6 a -c, f -h, k, l taken in CDCl 3 , the NH protons of the (E)-isomers 6a -c, f -h, k, l had lower δ values (∼ 6.2 ppm) than the 4 -H protons (∼ 7.7 ppm), while in the (Z)-isomers 6 a -c, f -h, k, l the NH protons exhibited higher δ values (∼ 9.9 ppm) than the 4 -H protons (∼ 7.2 ppm). Such a difference in chemical shifts of the NH protons in CDCl 3 solution could be explained by intramolecular N-H ··· O=C hydrogen bonding, which is possible only in the (Z)-isomers 6 a -c, f -h, k, l and not in the (E)-isomers 6a -c, f -h, k, l. Accordingly, in [D 6 ]DMSO as a hydrogen bond acceptor, the NH protons of the (E)-isomers 6d, e, j and 7a -c, e -j appear at ∼ 8. Fig. 2 ). (4) is an easily available reagent, which is suitable for two-step parallel solution-phase synthesis of 4-arylaminomethylidene-substituted (S)-pyroglutamic acids 7 as conformationally constrained analogues of Fig. 1 ). The synthesis comprises acid-catalysed substitution of the dimethylamino group in the enamino lactam 4 with aromatic and aliphatic primary amines 5 to give the substitution products 6/6 , followed by acidolytic deprotection to furnish the title compounds 7 in good yields over two steps. Furthermore, all intermediates 6a -l and final products 7a -c, e -j were obtained in analytical purity following a simple parallel filtration work-up protocol in both synthetic steps. In conclusion, this synthetic method offers an easy access to diversity-oriented libraries of (S)-4-[(substituted amino)methylidene]pyroglutamic acid derivatives in search for novel bioactive compounds.
Experimental Section
Melting points were determined on a Stanford Research Systems MPA100 OptiMelt automated melting point system. The NMR spectra were obtained on a Bruker Avance DPX 300 spectrometer at 300 MHz for 1 H and 75.5 MHz for 13 C, using CDCl 3 and [D 6 ]DMSO (with TMS as the internal standard) as solvents. Mass spectra were recorded on a Q-TOF Premier spectrometer, IR spectra on a Perkin-Elmer Spectrum BX FTIR spectrophotometer. Microanalyses were performed on a Perkin-Elmer CHN analyser 2400 II.
(S)-Pyroglutamic acid (1), di-tert-butoxy-bis(dimethylamino)methane (Bredereck s reagent), and amines 5a -l are commercially available (Sigma Aldrich). Di-tert-butyl (4) 
Parallel solution-phase synthesis of N(4 )-substituted di-tert-butyl (2S)-4-aminomethylidene-5-oxopyrrolidine-1,2-dicarboxylates 6/6 a -l
The MiniBlock TM was assembled with 12 fritted vessels, and the frits were wetted with ethanol (0.5 mL each). A stock solution of enaminone 4 (0.25 M in ethanol, 12 × 4 mL, 12 × 1 mmol) was added followed by addition of aqueous solutions of amines 5a -l hydrochlorides * (0.25 M in water, 12 × 5 mL, 12 × 1.2 mmol). The MiniBlock TM was closed and the reaction mixtures were stirred at 20 • C for 24 h. The precipitates were collected by filtration, washed with water (12 × 3 mL), and dried in vacuo at r. t. over P 4 O 10 for 24 h to give 6/6 a -l.
The following compounds were prepared in this manner:
Di-tert-butyl (2S,4E)-4-anilinomethylidene-5-oxopyrrolidine-1,2-dicarboxylate (6a) and its minor (4Z)-isomer 6 a
Compound 6a was prepared from 4 and aniline hydrochloride (5a). Yield: 365 mg (90 %) of a pale-beige * In the case of anilines 5i, j, the solid-free nitroanilines 5i and 5j were added to ethanolic solutions of 4, followed by addition of 0.25 M aq. HCl.
solid.
589 +19.5 (c = 0.33, CH 2 Cl 2 ). -IR (KBr): ν = 3237, 3120, 3040, 2978, 1757, 1710, 1686, 1639, 1594, 1495, 1445, 1369, 1313, 1231, 1151, 1000, 959, 866, 806, 775, 753, 692 C 64.93, H 7.27, N 7.21; found C 65.11, H 7.48, 
Di-tert-butyl (2S,4Z)-4-[(4-methylanilino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (6 c) and its minor (4E)-isomer 6c
Compound 6 c was prepared from 4 and 4-methylaniline hydrochloride (5c 
Di-tert-butyl (2S,4E)-4-[(3-hydroxyanilino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (6d)
Compound 6d C 62.36, H 6.98, N 6.93; found C 62.62, H 7.22, N 6.92 .
Di-tert-butyl (2S,4E)-4-[(4-hydroxyanilino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (6e)
Compound 6e 3321, 2978, 2935, 1724, 1695, 1634, 1519, 1433, 1391, 1369, 1321, 1225, 1150, 1005, 962, 822, 791, 745, 673 C 62.36, H 6.98, N 6.93; found C 62.66, H 7.21, N 7.09 .
Di-tert-butyl (2S,4Z)-4-[(3-methoxyanilino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (6 f) and its minor (4E)-isomer 6f
Compound 6 f was prepared from 4 and 3-methoxyaniline hydrochloride (5f). 3251, 3127, 2978, 2934, 1761, 1733, 1682, 1637, 1593, 1537, 1497, 1481, 1456, 1391, 1368, 1310, 1286, 1244, 1223, 1196, 1155, 1146, 1047, 997, 964, 929, 842, 768, 688 cm −1 . -1 H-NMR (CDCl 3 ), major (Z)-isomer 6 f: δ = 1.48 and 1.54 (18H, 2s, 1 : 1, 2 × t -Bu), 1.58 (0.7 H, s, 1 /3H 2 O), 2.61 (1H, ddd, J = 1. 3, 3.6, 15.3 Hz, 3.06 (1H, ddd, J = 1.3, 10.6, 15.3 Hz, C 62.25, H 7.28, N 6.60; found C 62.35, H 7.34, N 6.58 .
Di-tert-butyl (2S,4Z)-4-[(3-bromoanilino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (6 g) and its minor (4E)-isomer 6g
Compound 6 g was prepared from 4 and 3-bromoaniline hydrochloride (5g). 3295, 3260, 2979, 2933, 1763, 1734, 1716, 1686, 1638, 1594, 1475, 1368, 1312, 1236, 1223, 1154, 964, 899, 964, 773, 680 2980, 2934, 1759, 1725, 1687, 1638, 1588, 1485, 1454, 1368, 1312, 1231, 1152, 999, 960, 820, 775 C 53.97, H 5.82, N 5.99; found C 54.18, H 5.96, N 6 .00.
Di-tert-butyl (2S,4E)-4-[(4-bromoanilino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (6h) and its minor (4Z)-isomer 6 h

Di-tert-butyl (2S,4E)-4-[(3-nitroanilino)methylidene]-5-oxopyrrolidine-1,2-dicarboxylate (6i)
Compound 6i was prepared from 4 and 3-nitrolaniline (5i) in the presence of one equivalent of hydrochloric acid. = 3458, 3285, 3090, 2981, 2935, 1761, 1719, 1688, 1648, 1616, 1588, 1535, 1749, 1369, 1352, 1317, 1238, 1224, 1155, 999, 966, 845, 814, 777, 737, 674 cm −1 . -1 H-NMR (CDCl 3 ): δ = 1.48 and 1.51 (18H, 2s, 1 : 1, 2 × t -Bu), 2.67 (1H, ddd, J = 2.3, 2.9, 16.4 Hz, 3.09 (1H, ddd, J = 2.3, 10.5, 16.4 Hz, 4.56 (1H, dd, J = 3.3, 10.5 Hz, 7.07 (2H, d, J = 9.2 Hz, C 58.19, H 6.28, N 9.69; found C 58.34, H 6.44, methylidene]- 5-oxopyrrolidine-1,2-dicarboxylate (6j) Compound 6j = 3480, 3379, 3260, 3224, 3188, 2977, 1760, 1726, 1686, 1648, 1589, 1506, 1492, 1371, 1315, 1285, 1236, 1224, 1153, 1109, 999, 965, 876, 844, 775, 753, 693 C 58.19, H 6.28, N 9.69; found C 58.12, H 6.45, = 3286, 2979, 2936, 1755, 1728, 1686, 1622, 1458, 1370, 1314, 1257, 1194, 1152, 1094, 1025, 989, 945, 861, 846, 778, 764, 739, 716 cm −1 . -1 H-NMR (CDCl 3 ), major (E)isomer 6k: δ = 1.29 (3H, t, J = 7.1 Hz, CH 3 CH 2 ), 1.47 and 1.51 (18H, 2s, 1 : 1, 2 × t -Bu), 2.42 (1H, ddd, J = 2.0, 3.6, 15.4 Hz, 2.87 (1H, ddd, J = 2.0, 10.6, 15.4 Hz, C 57.27, H 7.59, N 7.03; found C 57.54, H 7.78, 3291, 3259, 2981, 2935, 1750, 1678, 1626, 1458, 1369, 1317, 1253, 1155, 1081, 1024, 1001, 952, 848, 773 C 58.24, H 7.82, N 6.79; found C 58.35, H 8.13, N 6.71 .
Parallel solution-phase synthesis of (2S,4E)-4-(anilinomethylidene)pyroglutamic acids 7a -c, e -j
The MiniBlock TM was assembled with 12 fritted vessels and charged with compounds 6/6 a -l (12 × 0.5 mmol) and 2M HCl-EtOAc (12 × 5 mL). The MiniBlock TM was closed and the reaction mixtures were stirred at 20 • C for 12 h. The precipitates were collected by filtration, washed with EtOAc (4 × 3 mL), and dried in vacuo at r. t. with P 4 O 10 for 24 h to give 7a -c, e -j. Compounds 7d, k, l, which did not precipitate from the reaction mixtures, were not isolated.
(2S,4E)-4-(Anilinomethylidene)pyroglutamic acid hydrochloride (7a)
Compound 7a was prepared from 6/6 a. 1730, 1665, 1587, 1489, 1325, 1244, 1204, 1086, 1075, 984, 819, 718, 652 = 3233, 3072, 2615, 2524, 2445, 1728, 1669, 1621, 1602, 1532, 1483, 1447, 1347, 1328, 1244, 1206, 1087, 986, 930, 814, 796, 739, 720, 663 calcd . C 45.95, H 3.86, N 13.40; found C 45.95, H 3.66, N 13.32 .
(2S,4E)-4-(4-Nitroanilinomethylidene)pyroglutamic acid (7j)
Compound 7j = 3296, 2920, 2533, 2440, 1725, 1669, 1593, 1556, 1500, 1317, 1242, 1218, 1111, 840, 750, 686 cm −1 . -1 H-NMR ( [D 6 ]DMSO): δ = 2.89 (1H, ddd, J = 2. 4, 3.5, 17.3 Hz, 3.17 (1H, ddd, J = 2.4, 9.7, 17.3 Hz, 4.26 (1H, dd, J = 3.5, 9.7 Hz, C 45.95, H 3.86, N 13.40; found C 46.26, H 4.12, N 13.31. 
